1. Home
  2. MOGO vs SNTI Comparison

MOGO vs SNTI Comparison

Compare MOGO & SNTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MOGO
  • SNTI
  • Stock Information
  • Founded
  • MOGO 2003
  • SNTI 2016
  • Country
  • MOGO Canada
  • SNTI United States
  • Employees
  • MOGO N/A
  • SNTI N/A
  • Industry
  • MOGO
  • SNTI Biotechnology: Pharmaceutical Preparations
  • Sector
  • MOGO
  • SNTI Health Care
  • Exchange
  • MOGO Nasdaq
  • SNTI Nasdaq
  • Market Cap
  • MOGO 42.5M
  • SNTI 39.6M
  • IPO Year
  • MOGO N/A
  • SNTI N/A
  • Fundamental
  • Price
  • MOGO $2.01
  • SNTI $1.72
  • Analyst Decision
  • MOGO Strong Buy
  • SNTI Strong Buy
  • Analyst Count
  • MOGO 1
  • SNTI 2
  • Target Price
  • MOGO $4.00
  • SNTI $8.50
  • AVG Volume (30 Days)
  • MOGO 269.9K
  • SNTI 138.9K
  • Earning Date
  • MOGO 11-05-2025
  • SNTI 11-13-2025
  • Dividend Yield
  • MOGO N/A
  • SNTI N/A
  • EPS Growth
  • MOGO N/A
  • SNTI N/A
  • EPS
  • MOGO 0.12
  • SNTI N/A
  • Revenue
  • MOGO $30,265,570.00
  • SNTI N/A
  • Revenue This Year
  • MOGO $61.97
  • SNTI N/A
  • Revenue Next Year
  • MOGO $4.03
  • SNTI $150.00
  • P/E Ratio
  • MOGO $16.74
  • SNTI N/A
  • Revenue Growth
  • MOGO 0.18
  • SNTI N/A
  • 52 Week Low
  • MOGO $0.74
  • SNTI $1.26
  • 52 Week High
  • MOGO $3.83
  • SNTI $16.94
  • Technical
  • Relative Strength Index (RSI)
  • MOGO 58.62
  • SNTI 69.62
  • Support Level
  • MOGO $1.77
  • SNTI $1.36
  • Resistance Level
  • MOGO $2.07
  • SNTI $1.43
  • Average True Range (ATR)
  • MOGO 0.11
  • SNTI 0.09
  • MACD
  • MOGO 0.01
  • SNTI 0.04
  • Stochastic Oscillator
  • MOGO 70.00
  • SNTI 79.55

About MOGO Mogo Inc.

Mogo Inc is a Canadian-based financial technology company. It offers a finance application to consumers with solutions that help them to control their financial health. At Mogo, users can sign up for a free account and get access to products and solutions that help users to monitor their credit score, protect themselves from identity fraud, control their spending, and borrow responsibly. Company offers digital loans and mortgages and also offer a digital payments platform that powers next-generation card programs for both established world-wide corporations and fintech companies in Europe and Canada.

About SNTI Senti Biosciences Inc.

Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.

Share on Social Networks: